CB1 Antisense in the Treatment of Liver Fibrosis
碩士 === 國立中山大學 === 生物醫學研究所 === 102 === Liver fibrosis results from chronic injury to the liver and inflammation activation of hepatic stellate cells produce excessive accumulation of type I collagen proteins, ultimately leads to cirrhosis, a major public health in Taiwan. Cannabinoid receptor 1 (CB1)...
Main Authors: | Pei-xuan Su, 蘇佩萱 |
---|---|
Other Authors: | Chang-Chun Hsiao |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/5er46b |
Similar Items
-
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018-06-01) -
Myocardial fibrosis and effect of AZT in myocardium of Y995CB mouse
by: Park, Jade
Published: (2015) -
Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides
by: James T. March, et al.
Published: (2018-06-01) -
Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
by: Beatrice Polini, et al.
Published: (2020-12-01) -
Adenoviral expression of a transforming growth factor-β1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats
by: Buettner Reinhard, et al.
Published: (2003-10-01)